News
XHE
86.37
0.00%
0.00
Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?
NASDAQ · 15h ago
Weekly Report: what happened at XHE last week (0212-0216)?
Weekly Report · 1d ago
SPDR S&P Health Care Equipment ETF -- Insider Buying Index Registering 10.1%
NASDAQ · 5d ago
Weekly Report: what happened at XHE last week (0205-0209)?
Weekly Report · 02/12 11:46
Dealmaking Outlook: Unsettled, With Bright Spots
Seeking Alpha · 02/07 06:53
Weekly Report: what happened at XHE last week (0129-0202)?
Weekly Report · 02/05 11:57
Barbell Equity Exposure In '24
Seeking Alpha · 01/31 09:36
Weekly Report: what happened at XHE last week (0122-0126)?
Weekly Report · 01/29 11:42
Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?
NASDAQ · 01/29 11:20
Weekly Report: what happened at XHE last week (0115-0119)?
Weekly Report · 01/22 11:48
Investing Themes For 2024
Home Investing Strategy Portfolio Strategy Investing Themes For 2024 Jan. 15, 2024 12:40 p.m. Jeff Spiegel is a regular guest on The Bid with Oscar Pulido. Jeff will provide an overview of three major investment themes for the year ahead. The themes include the emergence of medical innovation, the impact of geopolitical shifts on trade and the AI of the world.
Seeking Alpha · 01/15 17:40
Weekly Report: what happened at XHE last week (0108-0112)?
Weekly Report · 01/15 11:43
Week In Review: China Biopharmas Book $9B In Deals During JP Morgan Conference Week
Shanghai Argo Biopharma entered two agreements with Novartis for a total value of $4.2 billion. San Diego’s Ambrx Biopharmas will be acquired by Johnson & Johnson for $2billion. GSK plans to acquire Aiolos Bio for $1 billion upfront and up to $400 million.
Seeking Alpha · 01/14 08:40
Horiba: Wonderful Japanese Company At A Very Attractive Price
Horiba is a Japanese company that has a growing "Life Sciences Tools and Services" segment. The company has high market share in specialized devices in various industries. Horiba has outperformed the S&P 500 index by a significant margin over the past ten years. The Japanese company is likely undervalued and offers a rare combination of a quality business at an attractive price.
Seeking Alpha · 01/12 16:27
Analysts Anticipate XHE To Hit $98
NASDAQ · 01/11 11:01
Healthcare Outlook 2024
Healthcare sector was flat in 2023 year as a result of unique issues. Drug price regulation will be a serious challenge for the sector this year. We expect the broader S&P Healthcare Index to rise 10% in 2024. The healthcare sector is expected to gain 5%-10% in the first half of 2024.
Seeking Alpha · 01/08 13:31
Weekly Report: what happened at XHE last week (0101-0105)?
Weekly Report · 01/08 11:48
Week In Review: 2024 Kicks Off With 3 Deals Worth A Total Of $4B
Suzhou Ribo Life Science formed a collaboration with Boehringer Ingelheim in a deal that could be worth up to $2 billion. Suzhou MediLink Therapeutics out-licensed global rights for its pre-clinical ADC to Roche in a $1 billion agreement. Novartis acquired the 50% of Shanghai’s SanReno Therapeutic.
Seeking Alpha · 01/07 09:45
Stock Picker's Guide To 2024
Home Investing Strategy Portfolio Strategy Stock Picker's Guide To 2024. Global equity markets experienced a surge in 2023 driven by resilient economic growth and investor confidence. Tony DeSpirito: In 2024, investors should focus on quality, selectivity and agility in their investment approach.
Seeking Alpha · 01/06 13:15
IHI: High Valuation But Growing Healthcare Play
The iShares U.S. Medical Devices ETF provides broad exposure to the medical devices sector. The medical device industry is experiencing rapid growth and high demand. The fund has top holdings in Abbott Laboratories, Intuitive Surgical, and Medtronic. IHI is one of the largest ETFs in the medical device sector.
Seeking Alpha · 01/02 19:30
More
Webull provides a variety of real-time XHE stock news. You can receive the latest news about SPDR® S&P Health Care Equipment ETF through multiple platforms. This information may help you make smarter investment decisions.